These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17592752)

  • 21. Physicians' acceptance of pharmacists' interventions in daily hospital practice.
    Zaal RJ; den Haak EW; Andrinopoulou ER; van Gelder T; Vulto AG; van den Bemt PMLA
    Int J Clin Pharm; 2020 Feb; 42(1):141-149. PubMed ID: 32026348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities.
    Overhage JM; Lukes A
    Am J Health Syst Pharm; 1999 Dec; 56(23):2444-50. PubMed ID: 10595804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of clinical pharmacy interventions on medication error nodes.
    Chamoun NR; Zeenny R; Mansour H
    Int J Clin Pharm; 2016 Dec; 38(6):1436-1444. PubMed ID: 27770350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PROTECTED-UK - Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level.
    Rudall N; McKenzie C; Landa J; Bourne RS; Bates I; Shulman R
    Int J Pharm Pract; 2017 Aug; 25(4):311-319. PubMed ID: 27699912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation.
    Bourne RS; Dorward BJ
    Int J Clin Pharm; 2011 Oct; 33(5):755-8. PubMed ID: 21833712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP© website observatory.
    Bedouch P; Sylvoz N; Charpiat B; Juste M; Roubille R; Rose FX; Bosson JL; Conort O; Allenet B;
    J Clin Pharm Ther; 2015 Feb; 40(1):32-40. PubMed ID: 25303720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacist service in the acute ward.
    Nielsen TR; Andersen SE; Rasmussen M; Honoré PH
    Int J Clin Pharm; 2013 Dec; 35(6):1137-51. PubMed ID: 23979824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
    Umar RM; Apikoglu-Rabus S; Yumuk PF
    Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
    Finn A; Bondarenka C; Edwards K; Hartwell R; Letton C; Perez A
    J Oncol Pharm Pract; 2017 Dec; 23(8):563-574. PubMed ID: 27573921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of a medical admissions pharmacist in a hospital in Australia.
    Marotti SB; Cheh RM; Ponniah A; Phuong H
    Int J Clin Pharm; 2017 Apr; 39(2):403-407. PubMed ID: 28293768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proactive clinical pharmacist interventions in critical care: effect of unit speciality and other factors.
    Bourne RS; Choo CL; Dorward BJ
    Int J Pharm Pract; 2014 Apr; 22(2):146-54. PubMed ID: 23763333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partnered pharmacist charting on admission in the General Medical and Emergency Short-stay Unit - a cluster-randomised controlled trial in patients with complex medication regimens.
    Tong EY; Roman C; Mitra B; Yip G; Gibbs H; Newnham H; Smit DP; Galbraith K; Dooley MJ
    J Clin Pharm Ther; 2016 Aug; 41(4):414-8. PubMed ID: 27255463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system.
    Choi KS; Lee E; Rhie SJ
    Int J Clin Pharm; 2019 Apr; 41(2):424-433. PubMed ID: 30864079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of clinical pharmacist service on a neurology care unit.
    Yi ZM; Sun SS; Li XX; Lu M; Zhai SD
    Int J Clin Pharm; 2016 Feb; 38(1):30-3. PubMed ID: 26659084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.
    Malfará M; Pernassi M; Aragon D; Carlotti A
    Int J Clin Pharm; 2018 Jun; 40(3):513-519. PubMed ID: 29603074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of prescription errors by a unit-based clinical pharmacist in a nephrology ward.
    Vessal G
    Pharm World Sci; 2010 Feb; 32(1):59-65. PubMed ID: 19838816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an automated surveillance system using trigger alerts to prevent adverse drug events in the intensive care unit and general ward.
    DiPoto JP; Buckley MS; Kane-Gill SL
    Drug Saf; 2015 Mar; 38(3):311-7. PubMed ID: 25711668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.